Structures by: Kumar S. S.
Total: 23
C13H18ClNO2S
C13H18ClNO2S
Chemical communications (Cambridge, England) (2007) 8 867-869
a=6.7769(4)Å b=9.7641(8)Å c=11.4462(8)Å
α=76.916(5)° β=80.416(4)° γ=74.897(4)°
C15H19NO5
C15H19NO5
Chemical communications (Cambridge, England) (2007) 8 867-869
a=7.2564(6)Å b=7.4017(5)Å c=15.5988(13)Å
α=88.923(5)° β=85.403(5)° γ=62.334(4)°
C12H16N2O3
C12H16N2O3
Chemical communications (Cambridge, England) (2007) 8 867-869
a=18.6930(18)Å b=9.9424(8)Å c=14.9984(16)Å
α=90.00° β=122.342(10)° γ=90.00°
NAC
C5H9NO3S
CrystEngComm (2013) 15, 33 6498
a=5.1041(7)Å b=5.9092(8)Å c=6.5261(10)Å
α=96.484(12)° β=103.696(13)° γ=101.969(11)°
NAC
C5H9NO3S
CrystEngComm (2013) 15, 33 6498
a=6.0684(6)Å b=7.6372(9)Å c=16.005(2)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 2-[2-(4-methylbenzoyl)-5-<i>p</i>-tolyl-1<i>H</i>-imidazol-1-yl]acetate
C22H22N2O3
Acta Crystallographica Section E (2016) 72, 3 347-349
a=5.0968(5)Å b=13.8189(15)Å c=14.6993(17)Å
α=71.484(5)° β=84.018(5)° γ=82.531(5)°
6-Methyl-2,7-diphenyl-1,4-diazepan-5-one
C18H20N2O
Acta Crystallographica Section E (2009) 65, 12 o3211
a=10.8621(3)Å b=21.3210(7)Å c=13.3890(4)Å
α=90.00° β=91.167(2)° γ=90.00°
C66H104Al2N8
C66H104Al2N8
Organometallics (2004) 23, 26 6327-6329
a=9.0541(5)Å b=13.2183(7)Å c=13.4469(8)Å
α=87.230(5)° β=80.546(4)° γ=78.996(4)°
C66H103Al3N4O9
C66H103Al3N4O9
Inorganic Chemistry (2005) 44, 1199-1201
a=13.6221(9)Å b=14.5119(8)Å c=18.5448(10)Å
α=89.609(4)° β=80.735(5)° γ=67.620(5)°
C12H34O20Y2
C12H34O20Y2
Inorganic Chemistry (2005) 44, 9192-9196
a=8.8125(18)Å b=9.1769(18)Å c=10.346(2)Å
α=91.86(3)° β=113.97(3)° γ=117.91(3)°
C12H20O13Y2
C12H20O13Y2
Inorganic Chemistry (2005) 44, 9192-9196
a=15.857(3)Å b=16.469(3)Å c=8.3567(17)Å
α=90.00° β=115.94(3)° γ=90.00°
Niclosamide
C13H8Cl2N2O4
Crystal Growth & Design (2012) 12, 9 4588
a=13.485(2)Å b=7.0669(11)Å c=13.510(2)Å
α=90.00° β=98.345(2)° γ=90.00°
Niclosamide-caffeine
C13H8Cl2N2O4,C8H10N4O2
Crystal Growth & Design (2012) 12, 9 4588
a=7.8756(4)Å b=10.7632(6)Å c=25.8869(13)Å
α=90.00° β=96.2860(10)° γ=90.00°
Niclosamide-p-aminobenzoic acid
C13H8Cl2N2O4,C7H7NO2
Crystal Growth & Design (2012) 12, 9 4588
a=7.2810(14)Å b=12.763(2)Å c=12.789(2)Å
α=62.543(17)° β=76.384(16)° γ=74.384(15)°
Niclosamide-theophylline
C13H8Cl2N2O4,C7H8N4O2,C2H3N
Crystal Growth & Design (2012) 12, 9 4588
a=9.1371(7)Å b=10.8809(9)Å c=22.4497(17)Å
α=90.00° β=99.924(8)° γ=90.00°
Niclosamide-urea
C13H8Cl2N2O4,CH4N2O
Crystal Growth & Design (2012) 12, 9 4588
a=11.1272(10)Å b=16.9312(14)Å c=8.5708(7)Å
α=90.00° β=93.3120(10)° γ=90.00°
C13H12N2O2
C13H12N2O2
Crystal Growth & Design (2011) 11, 10 4594
a=14.2565(16)Å b=10.7542(15)Å c=14.769(3)Å
α=90.00° β=90.00° γ=90.00°
C13H12N2O2
C13H12N2O2
Crystal Growth & Design (2011) 11, 10 4594
a=9.0787(11)Å b=14.2261(17)Å c=17.154(2)Å
α=90.00° β=90.00° γ=90.00°
C13H12N2O2
C13H12N2O2
Crystal Growth & Design (2011) 11, 10 4594
a=9.250(4)Å b=14.207(4)Å c=17.509(10)Å
α=90.00° β=90.00° γ=90.00°
C18H18N4O2
C18H18N4O2
Crystal Growth & Design (2011) 11, 10 4594
a=6.8022(8)Å b=10.4120(12)Å c=23.206(3)Å
α=90.00° β=90.00° γ=90.00°
C27H22N4O10
C27H22N4O10
Crystal Growth & Design (2011) 11, 10 4594
a=7.8000(8)Å b=13.0415(16)Å c=14.0098(15)Å
α=64.870(11)° β=86.132(9)° γ=85.992(9)°
Niclosamide-theophylline-acetonitrile solvate
C13H8Cl2N2O4,C7H8N4O2,C2H3N
Crystal Growth & Design (2012) 12, 9 4588
a=8.579(3)Å b=10.733(4)Å c=13.216(5)Å
α=105.579(6)° β=94.104(6)° γ=96.024(6)°
C13H12N2O2
C13H12N2O2
Crystal Growth & Design (2011) 11, 10 4594
a=11.038(10)Å b=9.067(8)Å c=11.392(10)Å
α=90.00° β=101.860(14)° γ=90.00°